US Patent No: 7,728,031

Number of patents in Portfolio can not be more than 2000

Octahydro-pyrrolo[3,4-b]pyrrole derivatives

Stats

ALSO PUBLISHED AS: 20070232612
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

Octahydro-pyrrolo[3,4-b]pyrrole derivatives are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands, Octahydro-pyrrolo[3,4-b]pyrrole compounds, methods for using such compounds, compositions for making them, and processes for preparing such compounds are disclosed herein.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
ABBVIE INC.NORTH CHICAGO, IL672

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Black, Lawrence A - 51 89
Cowart, Marlon D Round Lake Beach, IL 78 83
Gregg, Robert J Libertyville, IL 13 28
Kolaczkowski, Lawrence Gurnee, IL 27 47
Sun, Minghua Cambridge, MA 39 48
Zhao, Chen Libertyville, IL 78 492
Zheng, Guo Zhu Lake Bluff, IL 28 86

Cited Art

Patent Info (Count) # Cites Year
 
PFIZER INC. (2)
2005/0245,543 Histamine-3 receptor antagonists 5 2005
2006/0019,998 Histamine-3 receptor antagonist 4 2005
 
ABBOTT LABORATORIES (1)
2004/0092,521 Bicyclic-substituted amines as histamine-3 receptor ligands 6 2002
 
ABBVIE INC. (1)
2005/0101,602 Substituted diazabicycloalkane derivatives 18 2004
 
ALANTOS PHARMACEUTICALS HOLDING, INC. (1)
2008/0221,093 Metalloprotease inhibitors containing a heterocyclic moiety 4 2008
 
BAYER AKTIENGESELLSCHAFT (1)
5,071,999 Preparation of 2,7-diazabicyclo[3.3.0]octanes 12 1990
 
PROBIODRUG AG (1)
7,462,599 Use of effectors of glutaminyl and glutamate cyclases 13 2004

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
ABBVIE INC. (1)
8,399,468 Octahydro-pyrrolo[3,4-B]pyrrole derivatives 0 2010

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 1, 2013
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 1, 2017
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 1, 2021
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00